Parkinson's Disease Trial, By Invitation NCT06104397 Sponsor: Shirley Ryan AbilityLab Condition: Parkinson's Disease
Printed from Voxsanity (voxsanity.com.au) — NCT06104397 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06104397
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A neurologist has confirmed the person has a diagnosis of Parkinson's Disease
  • The person's Parkinson's Disease is rated at Stage 1, 2, or 3 on the Hoehn & Yahr scale, which covers mild to moderate stages (confirm with trial site)
  • The person is between 18 and 89 years old
  • The person is able to walk and move around independently
  • The person has a basic ability to read, write, and speak English well enough to complete surveys
  • The person owns and uses a smartphone
  • The person is willing to sync an activity tracker with the Datos Health app at least once every 3 days
  • The person is willing to accept Datos' Terms and Conditions

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • The person has a recorded diagnosis of dementia or mild cognitive impairment in their medical records
  • The person uses a rollator or rolling walker to get around
  • The person has other health conditions that would significantly limit their ability to take part in exercise for more than 12 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Shirley Ryan AbilityLab
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
31 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accelerometer Measures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Other trials for Parkinson's Disease

  • NCT01793168 Sanford Health · Not Applicable · Recruiting · 🇦🇺 Australian site
  • NCT04071847 Abbott Medical Devices · Not Applicable · Recruiting · 🇦🇺 Australian site
  • NCT04643327 The University of Queensland · Phase 2 · Recruiting · 🇦🇺 Australian site
  • NCT06466525 Longevity Biotech Australia Pty Ltd (subsidiary) · Phase 1 · Recruiting · 🇦🇺 Australian site
  • NCT06732180 Gain Therapeutics, Inc. · Phase 1 · Recruiting · 🇦🇺 Australian site

Browse all trials for Parkinson's Disease →

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov